Remove Confidentiality Remove Intellectual Property Remove Marketing Remove Settlement
article thumbnail

Methods of Commercializing Intellectual Property – Part I

Intepat

Introduction Intellectual Property refers to those intangible assets which are created by virtue of the human intellect. The various forms of intellectual property are already well known- trademarks, patents, copyrights, industrial designs, trade secrets, domain names and geographical indications.

article thumbnail

Celltrion Stelara (Ustekinumab) Settlement With J&J

LexBlog IP

It has been reported that Celltrion has finalized a settlement with Johnson & Johnson (“J&J”) in the United States relating to CT-P43, Celltrion’s ustekinumab biosimilar to J&J’s STELARA®, which would permit Celltrion to launch the product in the U.S. market on March 7, 2025, if approved by FDA.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Formycon/Fresenius Kabi and Samsung Bioepis Settlements with J&J and Janssen Biotech regarding Ustekinumab

LexBlog IP

On August 7, 2023, Formycon AG and Fresenius Kabi announced that they have reached a settlement with Johnson & Johnson (“J&J”) in the United States relating to FYB202, a proposed ustekinumab biosimilar to STELARA®, marketed by J&J. Economic terms of the settlement were not disclosed in the press release.

article thumbnail

NDA: An Effective Way to Protect Confidential Information

LexBlog IP

Shi then left Elation to start a business marketing “similar, if not identical software” using replicated source code. Shi then left Elation to start a business marketing “similar, if not identical software” using replicated source code. The jury also found Shi breached the settlement agreement.

article thumbnail

Daniel Alexander KC says "no" on indemnity costs, blanket confidentiality orders and permission to appeal in Oxford University Innovation dispute

The IPKat

In the consequentials hearing judgment [2023] EWHC 138 , the Judge dealt with (1) royalty payments; (2) costs; (3) confidentiality; and (4) permission to appeal. Of the most interesting to this Kat was the treatment of costs (well, some of them), confidentiality and permission to appeal.

article thumbnail

Spring Cleaning: Decluttering From Recent Intellectual Property Detritus & Dusting Off Old Posts

LexBlog IP

” The need for spring cleaning, and a sense of coming out of hibernation, seems especially acute this April for this intellectual property lawyer. Beyond these IP cases and properties, the notion of spring cleaning has been applied to courts sorting through the issues before them.

article thumbnail

Medical Device Companies Settle Trade Secrets Dispute for $8,000,000

LexBlog IP

In 2017, Life Spine entered into various agreements with Aegis by which Aegis would sell and distribute ProLift devices while maintaining as confidential all proprietary information related to the devices. Aegis is a medical device manufacturer and distributor headquartered in California.